CTSL and neoplasm: Furthermore, there was no significant difference in cathepsin L expression between the tumors of patients who received neoadjuvant therapy and patients who did not (p = 0.164) or between patients who had tumor-positive lymph nodes and patients who did not (p = 0.723).